Navigation Links
CanDia5®

ProductsCanDia5®
Company Rockeby
Item CanDia5®
Features 
  • Rapid
  • High performance
  • Point of care (POC) test kit
  • Instantaneous
  • Highly accurate
  • Reliable results
Description For the first time in the world, there is a now a faster, more accurate and affordable way to diagnose VVC in female patients. CanDia5® is a simple-to-use, (POC) test kit that can accurately detect the Candida antigens almost instantaneously (within 5 minutes) with just a drop of the patients blood. There is no similar POC product for VVC diagnosis available on the market in the world. CanDia5® is highly accurate and specific. A clinical study showed that CanDia5® has a 78 percent rate of sensitivity and 90 percent rate of specificity for diagnosing VVC. The test result is consistent with 5 replications, indicating a high degree of reproducibility. This contributes to a higher chance of successful treatment and disease management for the VVC patient. CanDia5® saves both time and money for the patient and the doctor, providing a rapid, accurate diagnosis of VVC infection.
Info Rockeby
Customer Service: 65-6735-2368
Web site: http://www.rockeby.com/index.html

Related medicine products :

1. Candida Immunodiffusion System
2. Candida albicans IgG / IgM / IgA ELISA
3. Candida Antibody by ID
4. Candida Antigen
5. Candida IgG, IgM, & IgA Antibody Panel
6. Candida species DNA Probe
7. Allergen, Fungi & Molds, Candida albicans
8. Allergen, Fungi & Molds,Candida Albicans IgG
9. O.B.I.S. albicans
10. RAPID C. albicans IDENTIFICATION
... Head is clearly the favorite for most ... arms, the dual light heads rotate freely ... providing unlimited positioning. Engineered construction prevents any ... from minimally invasive through trauma to cardiovascular ...
... medical grade DVD recorder that features a built ... features DVORECOVERY™ and DVOFAST™, making this recorder one ... DVORECOVERY enables the end user to re-capture lost ... enables you to remove a recorded disk in ...
For the screening and detection by indirect immunofluorescence (IF) of primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously....
Medicine Products:
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, Fumie ... on 6th, 7th and 8th October at Miranda Kuo Gallery on Lower East Side, ... such as Zen Kodo mat. Wanderlust , one of the largest US yoga ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... of the Month, Lewis and Clark College Emeritus Professor of Education Gregory A. ... Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... of providing a voice for people who have kidney disease. The theme “Describe ... to share their stories. Entrants needed to meet only one qualification— to ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... the Orthodontics and Clear Aligner clinical and commercial support services market) has entered ... Dentistry (PGSD) in Sydney, Australia. , The PGSD is the first private ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... social campaign, “Humans With Vaginas.” The goal is to ignite conversation via social ... personal care products. The brand has declared September “Humans with Vaginas” month, releasing ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: